Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0001209191-24-001005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-05 | 2024-01-03+ | TVTX | Inrig Jula | Chief Medical Off | S - Sale | $9.43 | -2,509 | 35.7K | -7% | -$23.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | S | D | 440 | $9.17 | 35,248 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-03 | S | D | 2,069 | $9.48 | 35,688 | D | — | — |